Literature DB >> 17381623

Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.

Hubert Schrezenmeier1, Gabriele Walther-Wenke, Thomas H Müller, Franz Weinauer, Adelheid Younis, Tim Holland-Letz, Gabriele Geis, Jens Asmus, Ursula Bauerfeind, Jürgen Burkhart, Robert Deitenbeck, Elisabeth Förstemann, Wolfgang Gebauer, Britta Höchsmann, Apostolos Karakassopoulos, Ute-Maja Liebscher, Werner Sänger, Michael Schmidt, Friedrich Schunter, Walid Sireis, Erhard Seifried.   

Abstract

BACKGROUND: The GERMS Group initiated a prospective multicenter study to assess prevalence and nature of bacterial contamination of pooled buffy-coat platelet concentrates (PPCs) and apheresis platelet concentrates (APCs) by routine screening with a bacterial culture system. STUDY DESIGN AND METHODS: In nine centers overall, 52,243 platelet (PLT) concentrates (15,198 APCs, 37,045 PPCs) were analyzed by aerobic and anaerobic cultures (BacT/ALERT, bioMérieux).
RESULTS: In 135 PLT concentrates (PCs; 0.26%), bacteria could be identified in the first culture (0.4% for APCs vs. 0.2% for PPCs; p < 0.001). In 37 (0.07%) of these PC units, the same bacteria strain could be identified in a second culture from the sample bag and/or the PC unit. The rate of confirmed-positive units did not differ significantly between APC (0.09%; 1/1169) and PPC units (0.06%; 1/1544). Bacteria from skin flora (Propionibacterium acnes, Staphylococcus epidermidis) were the most prevalent contaminants. Median times to first positive culture from start of incubation were 0.7 and 3.7 days in aerobic and anaerobic cultures for confirmed-positive units. With a "negative-to-date" issue strategy, most PC units (55%) had already been issued by time of the first positive culture.
CONCLUSION: The rate of confirmed bacterial contamination of PC units was low. Nevertheless, clinicians must be aware of this risk. The risk of bacterial contamination does not warrant universal preference of APCs. It must be questioned whether routine bacterial screening by a culture method can sufficiently prevent contaminated products from being transfused due to the delay until a positive signal in the culture system and due to false-negative results.

Entities:  

Mesh:

Year:  2007        PMID: 17381623     DOI: 10.1111/j.1537-2995.2007.01166.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

1.  Supply with Platelet Concentrates from the Point of View of a Blood Donation Service of the Bavarian Red Cross.

Authors:  Franz Weinauer
Journal:  Transfus Med Hemother       Date:  2008-03-19       Impact factor: 3.747

2.  Effect of Safety Measures on Bacterial Contamination Rates of Blood Components in Germany.

Authors:  Gabriele Walther-Wenke; Walter Däubener; Margarethe Heiden; Jochen Hoch; Britt Hornei; Peter Volkers; Carl Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2011-07-11       Impact factor: 3.747

3.  Transfusion-Transmitted Bacterial Infections - Haemovigilance Data of German Blood Establishments (1997-2010).

Authors:  Markus B Funk; Annette Lohmann; Serife Guenay; Olaf Henseler; Margarethe Heiden; Kay-Martin O Hanschmann; Brigitte Keller-Stanislawski
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

4.  Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria.

Authors:  Thomas H Müller; Thomas Montag; Axel W Seltsam
Journal:  Transfus Med Hemother       Date:  2011-07-08       Impact factor: 3.747

5.  Direct detection of the bacterial stress response in intact samples of platelets by differential impedance.

Authors:  Ronald Rieder; Zhihui Zhao; Aphakorn Nittayajarn; Boris Zavizion
Journal:  Transfusion       Date:  2010-10-26       Impact factor: 3.157

Review 6.  Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies.

Authors:  Kathryn E Webert; Christine M Cserti; Judy Hannon; Yulia Lin; Katerina Pavenski; Jacob M Pendergrast; Morris A Blajchman
Journal:  Transfus Med Rev       Date:  2008-01

7.  Implementation of Bacterial Detection Methods into Blood Donor Screening - Overview of Different Technologies.

Authors:  Michael Schmidt; Walid Sireis; Erhard Seifried
Journal:  Transfus Med Hemother       Date:  2011-07-07       Impact factor: 3.747

8.  Reactions Induced by Platelet Transfusions.

Authors:  Volker Kiefel
Journal:  Transfus Med Hemother       Date:  2008-09-16       Impact factor: 3.747

9.  Efficacy and Adverse Events of Platelet Transfusion Product-Specific Differences.

Authors:  Peter Hellstern
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

10.  [Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy. A prospective cohort study].

Authors:  C F Weber; D Meininger; C Byhahn; E Seifried; K Zacharowski; E Adam; R Henschler; M M Müller
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.